ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,353Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 656

$1.84M Total Retail Price of All Prescriptions

Rank: 7 out of 656

626 Patients Receiving at Least One Drug in Part D
19%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 626 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

3% of this provider’s 626 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

3% of this provider’s 1,671 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$162 was the average price of a prescription from this provider, compared to $147 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
ZOLPIDEM TARTRATE 818 124 1 3
CYMBALTA 696 139 2 7
TRAZODONE HCL 649 96 3 1
ABILIFY 577 74 4 6
RISPERIDONE 522 83 5 2
DIVALPROEX SODIUM ER 509 52 6 10
SERTRALINE HCL 425 89 7 8
QUETIAPINE FUMARATE 407 67 8 5
CITALOPRAM HBR 395 84 9 9
BENZTROPINE MESYLATE 389 40 R 10 4
OLANZAPINE 364 37 11 12
MIRTAZAPINE 340 104 12 13
SEROQUEL XR 322 18 13 21
FLUOXETINE HCL 300 44 14 11
BUPROPION XL 293 35 15 17
ESCITALOPRAM OXALATE 286 79 16 18
PRISTIQ ER 273 46 17 30
BUSPIRONE HCL 227 23 18 19
VENLAFAXINE HCL ER 182 20 19 15
LITHIUM CARBONATE 160 0 20 16
LAMOTRIGINE 159 0 21 14
PAROXETINE HCL 158 33 22 23
LUNESTA 152 0 23 51
ZIPRASIDONE HCL 144 0 24 27
INVEGA 144 0 24 38
SEROQUEL 121 13 26 20
NAMENDA 120 81 27 22
CARBAMAZEPINE 107 14 28 35
SUBOXONE 102 16 29 45
OXCARBAZEPINE 98 0 30 28
TOPIRAMATE 91 0 31 34
AMPHETAMINE SALT COMBO 88 0 S2 32 37
LEXAPRO 77 14 33 47
PROPRANOLOL HCL 74 0 34 49
METHYLPHENIDATE HCL 74 0 34 56
DONEPEZIL HCL 74 54 34 33
DOXEPIN HCL 70 13 37 41
ZOLPIDEM TARTRATE ER 63 0 38 76
HALOPERIDOL 60 14 39 26
SAPHRIS 60 0 39 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 4, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.